Abstract
Seborrheic dermatitis (SD) is a chronic relapsing inflammatory process in the skin. SD has multiple clinical variants impacting both pediatric and adult populations as well as special populations such as those that are immunocompromised or suffer from neurologic disorders. SD often affects areas of the skin with greater sebaceous gland density and may cause a greasy appearance. Stress, anxiety, and emotion have all been suggested as both a trigger for and exacerbating factor of SD flares, however further investigation is required. Studies measuring quality of life indicate that SD may predispose patients to depression. Further, patients with SD often report embarrassment as a major complaint. The link between stress and SD should be carefully considered when caring for patients with SD. Management of both the psychological wellbeing and skin will have a potential synergistic effect on prognosis of patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gary G. Optimizing treatment approaches in seborrheic dermatitis. J Clin Aesthet Dermatol. 2013;6:44–9.
Naldi L, Rebora A. Clinical practice. Seborrheic dermatitis. N Engl J Med. 2009;360:387–96.
Berk T, Scheinfeld N. Seborrheic dermatitis. Pharm Ther. 2010;35:348–52.
Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol JEADV. 2004;18:13–26; quiz 19–20.
Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Physician. 2006;74:125–30.
Johnson MT, Roberts J. Skin conditions and related need for medical care among persons 1-74 years. United States, 1971–1974. Vital Health Stat 11. 1978:i–v, 1–72.
Peyrí J, Lleonart M, Grupo español del Estudio SEBDERM. Clinical and therapeutic profile and quality of life of patients with seborrheic dermatitis. Actas Dermosifiliogr. 2007;98:476–82.
Janniger CK. Infantile seborrheic dermatitis: an approach to cradle cap. Cutis. 1993;51:233–5.
Ooi ET, Tidman MJ. Improving the management of seborrhoeic dermatitis. Practitioner. 2014;258:23–6, 3.
Sonea MJ, Moroz BE, Reece ER. Leiner’s disease associated with diminished third component of complement. Pediatr Dermatol. 1987;4:105–7.
Sarifakioglu E, Yilmaz AE, Gorpelioglu C, Orun E. Prevalence of scalp disorders and hair loss in children. Cutis. 2012;90:225–9.
Williamson D, Gonzalez M, Finlay AY. The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol JEADV. 2001;15:137–9.
Wolf R, Orion E, Tüzün Y. Periorbital (eyelid) dermatides. Clin Dermatol. 2014;32:131–40.
Araya M, Kulthanan K, Jiamton S. Clinical characteristics and quality of life of seborrheic dermatitis patients in a tropical country. Indian J Dermatol. 2015;60:519.
Mathes BM, Douglass MC. Seborrheic dermatitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol. 1985;13:947–51.
Motswaledi MH, Visser W. The spectrum of HIV-associated infective and inflammatory dermatoses in pigmented skin. Dermatol Clin. 2014;32:211–25.
Soeprono FF, Schinella RA, Cockerell CJ, Comite SL. Seborrheic-like dermatitis of acquired immunodeficiency syndrome. A clinicopathologic study. J Am Acad Dermatol. 1986;14:242–8.
Senaldi G, Di Perri G, Di Silverio A, Minoli L. Seborrhoeic dermatitis: an early manifestation in AIDS. Clin Exp Dermatol. 1987;12:72–3.
Vidal C et al. Seborrheic dermatitis and HIV infection. Qualitative analysis of skin surface lipids in men seropositive and seronegative for HIV. J Am Acad Dermatol. 1990;23:1106–10.
Alessi E, Cusini M, Zerboni R. Mucocutaneous manifestations in patients infected with human immunodeficiency virus. J Am Acad Dermatol. 1988;19:290–7.
Blanes M et al. Current prevalence and characteristics of dermatoses associated with human immunodeficiency virus infection. Actas Dermosifiliogr. 2010;101:702–9.
Arsic Arsenijevic VS et al. A laboratory-based study on patients with Parkinson’s disease and seborrheic dermatitis: the presence and density of Malassezia yeasts, their different species and enzymes production. BMC Dermatol. 2014;14:5.
Shuster S et al. Melanocyte-stimulating hormone and parkinsonism. Lancet Lond Engl. 1973;1:463–4.
Cowley NC, Farr PM, Shuster S. The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders. Br J Dermatol. 1990;122:71–6.
Bettley FR, Marten RH. Unilateral seborrheic dermatitis following a nerve lesion. AMA Arch Dermatol. 1956;73:110–5.
Chen TM, Fitzpatrick JE. Unilateral seborrheic dermatitis after decompression of Chiari I malformation and syringomyelia. J Am Acad Dermatol. 2006;55:356–7.
Rocha N, Velho G, Horta M, Martins A, Massa A. Cutaneous manifestations of familial amyloidotic polyneuropathy. J Eur Acad Dermatol Venereol JEADV. 2005;19:605–7.
Ercis M, Balci S, Atakan N. Dermatological manifestations of 71 Down syndrome children admitted to a clinical genetics unit. Clin Genet. 1996;50:317–20.
Okada K et al. Refractory seborrheic dermatitis of the head in a patient with malignant lymphoma. Case Rep Dermatol. 2014;6:279–82.
Kokturk A et al. Seborrhoeic dermatitis-like manifestation of lung cancer evolving into erythrodermia. J Eur Acad Dermatol Venereol JEADV. 2004;18:381–2.
Venkateswaran S, Garg BR, Reddy BS, Narasimhan R. Cutaneous lymphoma mimicking seborrhoeic dermatitis. Indian J Dermatol Venereol Leprol. 1995;61:45–7.
Bittencourt AL, de Oliveira Mde FP. Cutaneous manifestations associated with HTLV-1 infection. Int J Dermatol. 2010;49:1099–110.
Tegner E. Seborrhoeic dermatitis of the face induced by PUVA treatment. Acta Derm Venereol. 1983;63:335–9.
Weiss SC, Rowell R, Krochmal L. Impact of seasonality on conducting clinical studies in dermatology. Clin Dermatol. 2008;26:565–9.
Picardi A, Abeni D. Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom. 2001;70:118–36.
Oztas P, Calikoglu E, Cetin I. Psychiatric tests in seborrhoeic dermatitis. Acta Derm Venereol. 2005;85:68–9.
Misery L et al. Stress and seborrheic dermatitis. Ann Dermatol Vénéréologie. 2007;134:833–7.
Maietta G, Fornaro P, Rongioletti F, Rebora A. Patients with mood depression have a high prevalence of seborrhoeic dermatitis. Acta Derm Venereol. 1990;70:432–4.
Orion E, Wolf R. Psychologic factors in the development of facial dermatoses. Clin Dermatol. 2014;32:763–6.
Humphreys F, Humphreys MS. Psychiatric morbidity and skin disease: what dermatologists think they see. Br J Dermatol. 1998;139:679–81.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Enos, C., Patel, T., Patel, S., França, K. (2017). Seborrheic Dermatitis. In: França, K., Jafferany, M. (eds) Stress and Skin Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-46352-0_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-46352-0_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-46351-3
Online ISBN: 978-3-319-46352-0
eBook Packages: MedicineMedicine (R0)